Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Receivables (2017 - 2025)

Catheter Precision (VTAK) has disclosed Receivables for 9 consecutive years, with $155000.0 as the latest value for Q4 2025.

  • Quarterly Receivables rose 121.43% to $155000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $155000.0 through Dec 2025, up 121.43% year-over-year, with the annual reading at $155000.0 for FY2025, 121.43% up from the prior year.
  • Receivables for Q4 2025 was $155000.0 at Catheter Precision, up from $123000.0 in the prior quarter.
  • The five-year high for Receivables was $228000.0 in Q2 2021, with the low at $17000.0 in Q3 2021.
  • Average Receivables over 5 years is $98058.8, with a median of $105000.0 recorded in 2024.
  • The sharpest move saw Receivables crashed 96.42% in 2021, then skyrocketed 207.69% in 2023.
  • Over 5 years, Receivables stood at $21000.0 in 2021, then increased by 23.81% to $26000.0 in 2022, then surged by 426.92% to $137000.0 in 2023, then plummeted by 48.91% to $70000.0 in 2024, then soared by 121.43% to $155000.0 in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $155000.0, $123000.0, and $115000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.